Clinical Trials Browser

Recurrence × loncastuximab tesirine × Clear all

NCT06918912 2025-04-09

LORELY

Phase 2 Recruiting

Lymphoma, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT04705454 2021-05-12

Loncastixumab Tesirine (ADCT-402) Expanded Access Program (EAP) for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

No longer available

Lymphoma, Recurrence, Lymphoma, Large B-Cell, Diffuse